Insmed’s shares recover as analysts highlight positive trial data
(Reuters) - Insmed Inc's shares plunged after its experimental drug to treat a form of bacterial lung infection failed the main goal of a trial, but the stock clawed back...
Home > Reviews
All Stories
La Jolla Pharma’s drug improves kidney function in trial, shares soar
(Reuters) - La Jolla Pharmaceutical Co said its lead experimental drug to treat chronic kidney disease met the main goal of improving kidney function in a mid-stage study, sending the...
La Jolla Pharma’s drug improves kidney function in trial, shares soar
(Reuters) - La Jolla Pharmaceutical Co said its lead experimental drug to treat chronic kidney disease met the main goal of improving kidney function in a mid-stage study, sending the...
FDA approves Anika Therapeutics arthritis drug; shares soar
(Reuters) - Anika Therapeutics Inc said the U.S. Food and Drug Administration approved its drug to treat pain and improve joint mobility in patients with osteoarthritis of the knee, more...
FDA approves Anika Therapeutics arthritis drug; shares soar
(Reuters) - Anika Therapeutics Inc said the U.S. Food and Drug Administration approved its drug to treat pain and improve joint mobility in patients with osteoarthritis of the knee, more...
Mallinckrodt’s extended-release pain drug meets main goal of study
(Reuters) - Specialty pharmaceutical company Mallinckrodt Plc said its experimental painkiller significantly reduced the intensity of pain in patients who had undergone a surgical removal of bunions. The drug, MNK-795,...
Mallinckrodt’s extended-release pain drug meets main goal of study
(Reuters) - Specialty pharmaceutical company Mallinckrodt Plc said its experimental painkiller significantly reduced the intensity of pain in patients who had undergone a surgical removal of bunions. The drug, MNK-795,...
Rockwell Medical’s iron deficiency drug succeeds in final study
(Reuters) - Rockwell Medical Inc said its lead experimental drug met the main goal of improving hemoglobin levels in its final late-stage trial among adult patients with chronic kidney disease....
Rockwell Medical’s iron deficiency drug succeeds in final study
(Reuters) - Rockwell Medical Inc said its lead experimental drug met the main goal of improving hemoglobin levels in its final late-stage trial among adult patients with chronic kidney disease....
Acura’s abuse-deterrent pain drug fails mid-stage study goal
(Reuters) - Acura Pharmaceuticals Inc said a painkiller made with its abuse-deterrent technology did not show statistically significant results in reducing likability among abusers, sending its shares down as much...